C. Carlin et al., Involvement of apolipoprotein E in multiple sclerosis: Absence of remyelination associated with possession of the APOE epsilon 2 allele, J NE EXP NE, 59(5), 2000, pp. 361-367
Citations number
40
Categorie Soggetti
Neurosciences & Behavoir
Journal title
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
Lipids are a major constituent of myelin and apolipoprotein E (apoE) plays
a key role in lipid transport. We therefore hypothesized that apoE is invol
ved in the processes of demyelination and remyelination. Furthermore as the
re is a biologically significant polymorphism in the APOE gene, the APOE ge
notype may influence the course of multiple sclerosis (MS). Specifically, a
s there is reduced affinity of the apoE E2 isoform for receptors on glial c
ells, we hypothesized that remyelination is impaired in individuals with th
e apoE epsilon 2 allele. We determined the apoE genotypes of 71 archival ca
ses of multiple sclerosis and 41 controls, reviewed the neurohistology, and
performed apoE immunohistochemistry. ApoE immunoreactivity was increased i
n demyelinated areas compared with control white matter. ApoE immunostainin
g was markedly increased in areas of active demyelination, specifically in
macrophages and astrocytes. The APOE allele frequencies of the cases of MS
(epsilon 2 = 0.06, epsilon 3 = 0.8, epsilon 4 = 0.13) resembled those of co
ntrols. Evidence of remyelination was identified in 25/71 MS cases (35%): i
n 25/64 patients (39%) without an epsilon 2 allele and 0/7 (0%) patients wi
th an epsilon 2 allele (p < 0.05). In conclusion, we provide evidence that
apoE is involved in the trafficking of lipid in MS and, although the number
of cases with this allele was small, remyelination may be defective in pat
ients with the APOE epsilon 2 allele.